OQROGet OQRO Pro
Insider trade

Repligen (RGEN)CEO sold ~$504K

Olivier Loeillot, CEO at Repligen, sold ~$504K of Repligen shares.

~$504K
Approx. value · 3,035 sh @ $165.90
48K
Holds after · shares reported
Traded
Sep 4, 2026
Filed
Sep 9, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 16, 2026InsiderCFO sold ~$80K of RGEN shares in the open market
  2. Jul 21, 2026Company filing · Form 8-K · Material agreement, ResultsSigned an important agreement, and reported its results (and 2 more items)
  3. Jul 28, 2026Company filing · Form 8-K · ResultsReported its results
  4. Aug 20, 2026InsiderCEO sold ~$977K of RGEN shares in the open market
  5. Sep 1, 2026Federal contract · $169K obligatedDepartment of Agriculture awarded REPLIGEN CORP: $169K obligated to date
  6. Sep 4, 2026 · this disclosureInsiderCEO sold ~$504K of RGEN shares in the open market

What came next

  1. Sep 10, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 10, 2026, Karen A. Dawes notified Repligen Corporation (“Repligen”) that she will be retiring from the Repligen Board of Directors (the “Board”) after over twenty years of distinguished service to Repligen, effective as of September 30, 2026.”
  2. Sep 21, 2026InsiderCEO sold ~$977K of RGEN shares in the open market
  3. Sep 24, 2026Insider · 1 personInsiders: 2 sales (~$2.5M)
  4. Oct 5, 2026Insider · 1 personInsiders: 2 sales (~$1.0M)
  5. Oct 6, 2026Company filing · Form 8-K · Acquisition or sale, Reg FDCompleted buying or selling a business or assets, and shared information with investors“The information set forth in the “Explanatory Note” of this Current Report on Form 8-K is incorporated by reference into this”
  6. Oct 7, 20265% stakeFMR LLC reported a passive stake (13G) of 13.0%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Repligen

For Repligen, OQRO holds 10 insider filings (SEC Form 4 or Form 144), 15 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RGEN page.

Other recent filings by Olivier Loeillot, Chief Executive Officer

The full history of Olivier Loeillot, Chief Executive Officer is on the profile page.

How this filing works

Other disclosures at Repligen

Everything OQRO holds on this company is on its RGEN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data